Cargando…
Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors
BACKGROUND: Left ventricular hypertrophy (LVH) is an independent cardiovascular risk factor in patients with essential hypertension. The main objective of this study was to assess the echocardiographic prevalence of left ventricular hypertrophy in patients with hypertension, its risk factors and eff...
Autores principales: | Jaleta, Gari Negeri, Gudina, Esayas Kebede, Getinet, Wondim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900673/ https://www.ncbi.nlm.nih.gov/pubmed/24444396 http://dx.doi.org/10.1186/1756-0500-7-45 |
Ejemplares similares
-
The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis
por: Fajar, Jonny Karunia, et al.
Publicado: (2019) -
Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy
por: A. Romero, Cesar, et al.
Publicado: (2021) -
Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy
por: van der Merwe, Lize, et al.
Publicado: (2008) -
Deletion Polymorphism of Angiotensin Converting Enzyme Gene is Associated with Left Ventricular Hypertrophy in Uighur Hypertension-Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Patients
por: Maitikuerban, Bumairemu, et al.
Publicado: (2019) -
Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study
por: Cosenso-Martin, Luciana Neves, et al.
Publicado: (2015)